STAT1/3/5 Functions Driving Lipid and Energy Metabolism in Cancer and Immunity
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27062828 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Mark Rinnerthaler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Medical Biology, Paris Lodron University of Salzburg, 5020 Salzburg, Austria. Hauptthemen laut MEDLINE: Neoplasms, Energy Metabolism, Lipid Metabolism, STAT1 Transcription Factor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FWF Austrian Science Fund, EU Interreg Projects EPIC, SENECA.
Abstract (Originalsprache)
Lipids are the major energy reservoir, but excessive fat accumulation drives immune cell trapping, chronic inflammation, autoimmunity, and cancer. Lipid synthesis, secretion, degradation, and the shuttling to cellular organelles and compartments are still poorly investigated in all cell types of the mammalian body. The major routes of FA uptake are dietary uptake, lipolysis, and de novo synthesis. We highlight disease associations zooming in on the Signal Transducer and Activator of Transcription 1/3/5 (STAT1/3/5) molecules in association with cytokine, growth factors, and hormone action, steering lipid metabolism. We compare STAT-lipid crosstalk from nuclear and mitochondrial perspectives, highlighting roles in immunity, metabolic diseases, and cancer, and providing insights into key regulatory mechanisms of lipid metabolism. A high degree of cellular flexibility in metabolic adaptation explains the need for fine-tuning, in which STAT molecules can function as rheostats to maintain energy equilibrium within cellular compartments. This concept bridges, e.g., high-energy flux or the Warburg effect, with the Hydride Transfer Complex upon low-energy provision. Another interesting STAT1/3/5 aspect is their Lipid droplet (LD) association and LD formation. LDs play key roles in disease initiation or progression, including autoimmunity or cancer, as well as chronic inflammatory diseases due to their role in (1) lipotoxicity, (2) cell death regulation, (3) immune system amelioration, and (4) energy provision. Finally, the therapeutic consequences of the angles are outlined, along with future research directions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences and Medical Biology, Paris Lodron University of Salzburg, 5020 Salzburg, Austria.
- Department of Biosciences and Medical Biology, Cancer Cluster Salzburg, Paris Lodron University of Salzburg, 5020 Salzburg, Austria.
- Center for Tumour Biology and Immunology, Paris Lodron University of Salzburg, 5020 Salzburg, Austria.
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC H2X 0A9, Canada.
- Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montreal, QC H3C 3J7, Canada.
ORCID-Profile: Mark Rinnerthaler, Fritz Aberger, Gerardo Ferbeyre
Förderung
- FWF Austrian Science Fund
- EU Interreg Projects EPIC
- SENECA
- Cancer Cluster Salzburg
- Biomed Center Salzburg
- Priority program
Zitieren
APA
Rinnerthaler, M., Sykora, M., Christoforakos, A., Aberger, F., Ferbeyre, G., & Moriggl, R. (2026). STAT1/3/5 Functions Driving Lipid and Energy Metabolism in Cancer and Immunity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27062828
Vancouver
Rinnerthaler M, Sykora M, Christoforakos A, Aberger F, Ferbeyre G, Moriggl R. STAT1/3/5 Functions Driving Lipid and Energy Metabolism in Cancer and Immunity. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27062828
BibTeX
@article{Rinnerthaler2026,
author = {Rinnerthaler, Mark and Sykora, Martina and Christoforakos, Anastasios and Aberger, Fritz and Ferbeyre, Gerardo and Moriggl, Richard},
title = {STAT1/3/5 Functions Driving Lipid and Energy Metabolism in Cancer and Immunity},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27062828}
}
EUVIMED